Literature DB >> 18487877

Association of serum lipid profile and arteriovenous fistula thrombosis in maintenance hemodialysis patients.

Alper Kirkpantur1, Mustafa Arici, Bulent Altun, Mahmut Ilker Yilmaz, Barbaros Cil, Tuncay Aki, Mehmet Bakkaloglu, Cetin Turgan.   

Abstract

BACKGROUND: Vascular access thrombosis represents a major cause of morbidity in the hemodialysis population. The role of serum lipid profile in access thrombosis is not sufficiently established. The aim of this study was to investigate the association between serum lipid profile and native arteriovenous fistula (AVF) thrombosis.
METHODS: Clinical files of 99 maintenance hemodialysis patients were reviewed retrospectively for 3 years. Serum lipid profile, albumin and C-reactive protein (CRP) were measured. Catheter angiography was performed in patients with AVF dysfunction and AVF thrombosis.
RESULTS: Patients with AVF thrombosis and patent AVF had similar serum levels of total cholesterol and triglyceride levels. However, patients with AVF thrombosis had significantly lower low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and albumin and higher serum CRP levels than patients with patent AVFs.
CONCLUSIONS: Serum levels of lipid subfractions are associated with AVF thrombosis in maintenance hemodialysis patients. Larger and prospective cohort studies are needed to confirm these observations. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18487877     DOI: 10.1159/000132388

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  7 in total

1.  Relationship between serum sclerostin, vascular sclerostin expression and vascular calcification assessed by different methods in ESRD patients eligible for renal transplantation: a cross-sectional study.

Authors:  Min Li; Hua Zhou; Min Yang; Changying Xing
Journal:  Int Urol Nephrol       Date:  2018-12-04       Impact factor: 2.370

2.  Vein tissue expression of matrix metalloproteinase as biomarker for hemodialysis arteriovenous fistula maturation.

Authors:  Eugene S Lee; Qiang Shen; Robert L Pitts; Mingzhang Guo; Mack H Wu; Sarah Y Yuan
Journal:  Vasc Endovascular Surg       Date:  2010-08-18       Impact factor: 1.089

3.  Significant association of anti-platelet factor 4/heparin antibody with cardiovascular disease in hemodialysis patients: a longitudinal 7-year study.

Authors:  Chi-Chu Liu; Li-Ping Chou; Tsang-Shan Chen; Chien-An Chen; Yueh-Feng Tsai
Journal:  Int Urol Nephrol       Date:  2018-10-15       Impact factor: 2.370

4.  Systemic Profile of Cytokines in Arteriovenous Fistula Patients and Their Associations with Maturation Failure.

Authors:  Laisel Martinez; Mikael Perla; Marwan Tabbara; Juan C Duque; Miguel G Rojas; Nieves Santos Falcon; Simone Pereira-Simon; Loay H Salman; Roberto I Vazquez-Padron
Journal:  Kidney360       Date:  2022-01-13

5.  Sclerostin as a new key player in arteriovenous fistula calcification.

Authors:  M Balcı; A Kırkpantur; A Turkvatan; S Mandıroglu; E Ozturk; B Afsar
Journal:  Herz       Date:  2013-10-19       Impact factor: 1.443

Review 6.  Maturation of arteriovenous fistula: Analysis of key factors.

Authors:  Muhammad A Siddiqui; Suhel Ashraff; Thomas Carline
Journal:  Kidney Res Clin Pract       Date:  2017-12-31

7.  A Systematic Review and Meta-Analysis of Circulating Biomarkers Associated with Failure of Arteriovenous Fistulae for Haemodialysis.

Authors:  Susan K Morton; Alexander J Rodríguez; Dylan R Morris; Abhishta P Bhandari; Joseph V Moxon; Jonathan Golledge
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.